Fig. 3From: Effect of thoracic radiotherapy dose on the prognosis of advanced lung adenocarcinoma harboring EGFR mutationsComparison of OS between < 50 Gy and ≥ 50 Gy groups (A). Comparison of OS between < 60 Gy and ≥ 60 Gy groups (B). Overall survival (OS) of patients according to different thoracic radiotherapy doses (C)Back to article page